Characterization of avirulent mutant Legionella pneumophila that survive but do not multiply within human monocytes by unknown
CHARACTERIZATION OF AVIRULENT MUTANT
LEGIONELLA PNEUMOPHILA THAT SURVIVE BUT DO NOT
MULTIPLY WITHIN HUMAN MONOCYTES
BY MARCUS A. HORWITZ
From theDivision ofInfectious Diseases, Department ofMedicine, University ofCalifornia at
Los Angeles, School ofMedicine, Centerfor the Health Sciences, Los Angeles, California 90024
Legionella pneumophila, the causative agent of Legionnaires' disease, is a
facultative intracellular bacterial pathogen that multiplies intracellularly in hu-
man monocytes and alveolar macrophages (1, 2). In addition to humans, the
organism is highly virulent for guinea pigs and lethal to this animal by both the
intraperitoneal and aerosol routes of inoculation (3-5).
Virulence of L. pneumophila is likely dependent upon several characteristics of
thisorganism. First, L. pneumophila is resistant to thebactericidal effects ofserum
(6). Second, the bacterium is highly resistant to killing by monocytes, polymor-
phonuclear leukocytes, and alveolar macrophages (2, 6, 7). Third, the organism
multiplies within mononuclear phagocytes including monocytes and alveolar
macrophages (1, 2). This last characteristic of L. pneumophila is dependent upon
its capacity to enter mononuclear phagocytes, which it does by a process termed
coiling phagocytosis (8), and may be dependent upon its capacity to form a
distinctive ribosome-lined replicative phagosome (9), to inhibit phagosome-lyso-
some fusion (10), and to inhibit phagosome acidification (11).
Mutants, particular avirulent mutants, can be powerful tools for analyzing
virulence determinants. When passaged on suboptimal artificial media, L. pneu-
mophila spontaneously converts to a mutant form avirulent for guinea pigs (12).
Neither the functional nor genetic basis for this avirulent phenotype has been
characterized. Theoretically, avirulent mutants would fall into two general
phenotypic classes herein designated types I and II. Type I mutants would be
those unable to survive extracellularly, e.g., complement-sensitive mutants. Type
II mutants would be those unable to replicate in host mononuclear phagocytes.
The latter classmight include threefunctional subclasses ofmutants. One subclass
(type IIA) would be those unable to enter mononuclear phagocytes and thus
gain entry into the intracellular milieu the organism requires to replicate. A
second subclass of mutants (type IIB) would be those able to enter mononuclear
phagocytes but unable to survive intracellularly, e.g., a mutant that has lost its
capacity to resist an antimicrobial substance produced by the phagocyte. A third
subclass of mutants (type IIC) would be those able to enter and survive within
mononuclear phagocytes but unable to multiply intracellularly.
M. A. Horwitz is a Gordon McDonald Scholar at the University of California, Los Angeles and a
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The objective of the present study was to characterize a spontaneously occur-
ring mutant of L. pneumophila. This study will show that this mutant is a type
IIC mutant as defined above, i.e., the mutant is able to enter and survive within
human monocytes, but it is unable to multiply intracellularly. In addition, this
study will show that this mutant enters monocytes in the usual way, i.e., coiling
phagocytosis, but that the mutant does not form the distinctive replicative
phagosome characteristic of the wild-type nor inhibit phagosome-lysosome fu-
sion. The mutant survives intracellularly in a phagolysosome.
Materials and Methods
Media.
￿
Egg yolk buffer (EYB),' with or without 1 % BSA, PBS, and RPMI 1640
medium were prepared or obtained as described previously (1). Antibiotics were not
added to media in any of the experiments.
Agar. Buffered charcoal yeast extract (CYE) agar was prepared as described (1).
Mueller-Hinton agar supplemented with 1 % hemoglobin and 2% Iso Vitalex was pur-
chased from Baltimore Biological Laboratories, Cockeysville, MD.
Serum.
￿
Normal (nonimmune) human sera were obtained from adult donors not known
to have had Legionnaires' disease as described (1). All sera had indirect fluorescent
antibody (IFA) anti-L. pneumophila titers of <1 :64. Immune human serum with an IFA
anti-L. pneumophila titer of 1 :65,536 or 1 :512 were obtained from adult donors who had
recently recovered from Legionnaires' disease.
Bacteria.
￿
Wild-type L. pneumophila, Philadelphia 1 strain, was grown in embryonated
hens' eggs, harvested, tested for viability and for the presence of contaminating bacteria,
as described (1). The bacteria were passed one time only on CYE agar and stored at
-70°C.
Mutant bacteria were selected by passaging wild-type L. pneumophila on supplemented
Mueller-Hinton agar. The bacteria were batch passaged at 4-d intervals nine times. Then
44 colonies were selected and passaged individually an additional three times. The 44
mutants were then passaged on CYE agar, harvested, and stored at -70'C. All 44 mutants
were identified as L. pneumophila by the direct fluorescent antibody assay using fluorescein-
conjugated anti-L. pneumophila antiserum. All 44 mutants were tested for the presence
of contaminants by culture on CYE agar without cysteine, tryptic soy broth agar, and 5%
sheep blood tryptic soy brothagar, none of which support growth ofL. pneumophila;none
of the cultures grew on these media.
Escherichia coli K 12, strain MC4100, is a complement-sensitive rough unencapsulated
strain without an O antigen on its LPS (13). E. coli serotype 09:K29-:H- (E. coli K-), an
unencapsulated mutant derived from strain Bi 161-42, is a smooth bacterium with an O
antigen on its LPS (14).
Human BloodMononuclearCells.
￿
Blood mononuclear cellswere obtained from normal
adult donors not known to have previously had Legionnaires' disease and with an IFA
anti-L. pneumophila titer of <1 :64 as described (1).
Bacterial Intracellular Multiplication Assay.
￿
Freshly explanted monocytes were purified
and cultured as a monolayer in 16-mm diameter flat-bottomed wells in 0 .5 ml of RPMI
1640 medium containing 20% fresh normal human serum as described (13). Then, wild-
type or mutant L. pneumophila were added to the cultures. The cultures were incubated
at 37°C in 5% C02-95% air on a gyratory shaker (100 rpm) for 1 h and under stationary
conditions thereafter. CFU of L. pneumophila in each culture were determined daily after
infection as described (1).
Serum Bactericidal Activity.
￿
Wild-type L. pneumophila, mutant L. pneumophila, and E.
coli K12 (a serum-sensitive control) were suspended in PBS containing 0, 10, 25, or 50%
fresh normal human serum and 0 or 20% heat-inactivated human immune serum with an
' Abbreviations used in this paper:
￿
AYE broth, albumin yeast extract broth; CYE agar, buffered
charcoal yeast extract agar; EYB, egg yolk buffer; EYB-BSA, egg yolk buffer containing 1 % BSA;
IFA, indirect fluorescent antibody assay; YE, yeast extract broth.1312
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anti-L. pneumophila serogroup 1 IFA titer of 1 :65,536 or 1 :512. The bacteria were
incubated in plastic test tubes in a total volume of 0.5 ml at 37°C for 0, 1, or 24 h. At
the end of the incubation, the contents of each tube were serially diluted in EYB-BSA,
and assayed for CFU of L. pneumophila on CYE agar or CFU of E. coli on blood agar as
described (6).
Bacterial Binding Assay.
￿
Wild-type or mutant L. pneumophila (5 X 107 bacterial parti-
cles/ml) were incubated in plastic test tubes with mononuclear cells(2 X 107/ml) in RPMI
and 20% heat-inactivated normal serum at 37°C in 5% C02-95% air on a gyratory shaker
at 200 rpm for 30 min. After the incubation, 100-,u1 aliquots of the suspension were
placed on 13-mm diameter glass cover slips and the preparation was incubated for 1.5 h
at 37°C in 5% C02-95% air to allow the monocytes to adhere. The coverslips were
washed three times in RPMI, and the cells were fixed and stained with fluorescein-
conjugated rabbit anti-L. pneumophila antiserum as described (1), and examined by
fluorescence microscopy. 200 consecutive monocytes were examined and the percentage
of monocytes with cell-associated bacteria and the mean number of bacteria/monocyte
were determined.
BacterialIntracellularSurvivalAssay.
￿
Intracellular survival was examined by two assays.
In the first assay, wild-type or mutant bacteria (102-106 CFU/ml) were mixed in a conical
centrifuge tube with mononuclear cells (106/ml) at 4°C in RPMI containing 10% heat-
inactivated serum in a total volume of 0.5 ml. The cell preparation was centrifuged at
4°C, first at 220 g for 10 min and then at 850 g for 20 min, so that the bacteria and
leukocytes were pelleted together in the cone of the centrifuge tube. The centrifuge tubes
were placed in a 37 °C water bath and the bacteria and leukocytes were incubated together
in the cone of the tubes for 0 or 2 h. Under these conditions, bacteria are rapidly
internalized (8); this was confirmed for mutant L. pneumophila by electron microscopy
(see below). The cells were then resuspended and sonicated for 10 s continuously with a
microtip attached to a sonicator (Heat Systems-Ultrasonics, Inc., Farmingdale, NY) under
sterile conditions with the output control of the sonicator set at the three position; this
amount of sonic energy lysed the mononuclear cells completely but did not reduce
bacterial CFU. CFU in replicate cultures were then determined.
In the second assay, wild-type L.pneumophila (106 CFU/ml), Mutant 25C (106 CFU/ml),
or Mutant 25D (10 CFU/ml) were added to monocytes that had been cultured 1 d in
monolayer culture in RPMI containing 20% fresh normal serum. The cultures were
incubated at 37°C for 30 min on a gyratory shaker at 100 rpm and washed four times
with RPMI to remove extracellular bacteria. The infected monocytes were resuspended
in RPMI containing 20% serum, incubated for 0, 4, or 24 h and sonicated for 5 s with a
0.5-inch diameter disruptor horn with the output control of the sonicator set at the 2 .5
position; under these conditions of sonication, CFU are not reduced. CFU in triplicate
cultures were determined.
Phagocytosis Assay.
￿
Phagocytosis of wild-type and mutant L. pneumophila was studied
by electron microscopy as described (8). Briefly, monocytes and bacteria were mixed and
pelleted together at 4° C in the cone of a centrifuge tube, rapidly warmed to 37 °C for a
few minutes to allow phagocytosis to proceed, and fixed for electron microscopy.
Phagosome Formation Assay.
￿
The interaction of phagosomes of wild-type and mutant
L. pneumophila with monocyte organelles was studied as described (9) or by a modification
that simplified embedding and allowed the experiments to be conducted with much fewer
monocytes that were cultured on plastic cover slips. Briefly, monocytes were cultured for
1 d as a monolayer in 35-mm diameter plastic petri dishes or at the center of 14-mm
diameter toluene-resistant plastic cover slips (Wako Chemical Co., Dallas, TX) placed in
16-mm diameter tissue culture wells (14). The monocytes were infected with wild-type or
mutant L. pneumophila, washed vigorously to remove non-monocyte-associated bacteria,
incubated for 1, 2, 6, or 24 h, and fixed for electron microscopy. Monocytes in plastic
petri dishes were released from the surface of the dishes with propylene oxide and
embedded as described (9). Monocytes on plastic cover slips were embedded while on the
cover slip, and the cover slips were peeled away from the basal surface of the monocytes
before sectioning. The sections were stained with lead citrate and uranyl acetate asHORWITZ
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described (9) and examined with a JEOL JEM-100 CX electron microscope (JEOL, Ltd.,
Tokyo,Japan). In each experiment, at least20 phagosomescontaining wild-type or mutant
L. pneumophila were studied at each time point. Phagosomes were examined for the
presence of smooth vesicles, mitochondria, and ribosomes closely apposed to the external
phagosomal membrane.
Phagosome-Lysosome Fusion Assay.
￿
Fusion of phagosomes containing wild-type or mu-
tant L. pneumophila with monocyte lysosomes prelabeled with the electron-opaque marker
thorium dioxide was studied by electron microscopy as described (10). Briefly, monocytes
in monolayer culture (in petri dishes or on plastic coverslips as in the phagosome formation
assay) were incubated at 37 ° C overnight with thorium dioxide, washed vigorously to
remove unbound thorium dioxide, and incubated an additional 3 h to allow monocytes
to internalize thorium dioxide absorbed on the cell surface and to concentrate the marker
in lysosomes. The monocytes were then infected with live or formalin-killed, wild-type,
or mutantL. pneumophila, washed to remove non-monocyte-associatedbacteria, incubated
1, 6, or 24 h, and fixed and processed for electron microscopy. In each experiment, at
least 20 phagosomes containing wild-type or mutant L. pneumophila were studied at each
time point. Phagosomes were examined for the presence of thorium dioxide, indicating
that fusion had taken place with lysosomes.
ProteinProfile ofWhole Bacteria.
￿
Wild-type and mutant L. pneumophila were suspended
in 1 ml EYB to an OD of 0.8 at 540 nm, as measured in a Coleman 44 model
spectrophotometer (Perkin-Elmer Corp., Norwalk, CT), twice pelleted by centrifugation,
and washed in 50 mm Tris-HCI buffer, pH 7.4, resuspended in 200 Al of SDS-PAGE
sample buffer containing 125 mM Tris-HCI, 20% glycerol (Fisher Scientific Co., Pitts-
burgh, PA), 4% SDS (BDH Chemicals Ltd., Poole, England), 4 mM EDTA disodium salt
(Sigma Chemical Co., St. Louis, MO), 10% 2-ME (Sigma Chemical Co.), and 0.01
bromophenol blue (Sigma Chemical Co.), pH 6.8, and heated at 100 00'C for 5 min. Proteins
in the sample buffer were analyzed by SDS-PAGE (reagents from BDH Chemicals Ltd.)
performed according to Laemmli (17) as modified by Ames (18). The separating gel
contained 12.5% acrylamide and 0.33% N,N'-methylene bis-acrylamide. 50 '1 of each
preparation were loaded onto the gel. Molecular weight standards were obtained from
Sigma Chemical Co. After electrophoresis, the gels were fixed in 10% acetic acid, 25%
isopropanol, and stained for proteins with 0.2% Coomassie Brilliant Blue R-250 (Sigma
Chemical Co.) in fixing solution.
Secretory Proteins.
￿
Secretory proteins of wild-type and mutant L. pneumophila were
studied by radiolabeling the proteins with [s5S]-L-cysteine, subjecting the proteins to SDS-
PAGE, and revealing the radiolabeled polypeptides autoradiographically. Bacteria were
grown in yeast extract (YE) broth, equivalent to AYE broth without albumin, at 37 0 C to
an OD of 0 .5-1 .0, pelleted by centrifugation, resuspended in L-cysteine-deficient YE
broth (containing 0.001% L-cysteine), and grown to an OD of 0.6. Then 0 .1 mCi [s5S]-
cysteine (New England Nuclear, Boston, MA) was added per milliliter of bacterial
suspension and the bacteria were incubated in a test tube for 20 min at 37°C at 120 rpm.
The bacteria were pelleted by centrifugation at 15,600 g for 10 min at 4°C in an
Eppendorfcentrifuge, and the supernatant was filtered through 0.2-'Um filters (Millipore,
Bedford, MA) to remove any residual membranes. Previous experiments had demon-
strated that this procedure removes all residual bacterial membranes and that ultracen-
trifugation of the preparation is unnecessary. Proteins were precipitated by adding 200
ul of 60% TCA (Fisher Scientific Co.) per milliliter of supernatant fluid, vortexing
immediately, and incubating at 4°C overnight. The protein precipitate in each milliliter
of fluid was collected by centrifugation at 15,600 g for 20 min at 4 °C, resuspended in 1
ml cold 50 mM sodium acetate in ethanol, collected by centrifugation, resuspended in 1
ml acetone (4'C), collected by centrifugation, dried in a dessicator for 20 min, resuspended
in 200 Ml sample buffer, heated to 100°C until completely dissolved, and heated an
additional 5 min at 100°C. The proteins were diluted 16- or 32-fold in sample buffer and
40-dal aliquots loaded onto 14% polyacrylamide-urea gels, prepared as described above.
Radiolabeled polypeptides were revealed by autoradiography of the dried gel using x-ray
film (Kodak X-Omat XAR-5 film; Eastman Kodak Co., Rochester, NY). As a control,1314
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I31S]-L-cysteine was added to L-cysteine-deficient YE broth from which bacteria were
removed, andthe brothwasprocessedin parallel with thesupernatants ofbrothinoculated
with bacteria. Such broth controls were always negative for radiolabeled polypeptides.
Lipopolysaccharide Assay.
￿
Wild-type and mutant LPS was isolated, subjected to SDS-
PAGE (14% acrylamide, 4 M urea), andthegel was stained with silver nitrate as described
(13) with the kind assistance of Dr. Joel Gabay (The Rockefeller University, New York).
Results
All Mutant Clones of L. pneumophila Are Avirulent for Human Monocytes.
￿
44
mutant clones were selected and assayed for their capacity to multiply in human
monocytes in monolayer culture. None of the 44 mutant clones multiplied at all
in experiments in which wild-type L. pneumophila multiplied 2.5-4.5 logs. An
experiment representative of five experiments that compared growth of Mutant
25 with that of wild-type is shown in Fig. 1 ; growth of the other mutants
resembled that of Mutant 25.
Paralleling these results, all monocyte monolayers infected with the 44 clones
of mutant L. pneumophila were completely intact 5 d after infection whereas
monocyte monolayers infected with wild-type L. pneumophila were destroyed by
3 d after infection.
Thus, in contrast to wild-type L. pneumophila, the mutant L. pneumophila do
not multiply in monocytes nor produce a cytopathic effect on monocyte mono-
layers.
Colony Morphology and Ultrastructure of Mutant L. pneumophila.
￿
Mutant L.
pneumophila formed both diffuse and compact colonies on CYE agar similar in
morphology to colonies formed by wild-type L. pneumophila (Fig. 2); as with the
wild-type bacteria, the formation of these colony types paralleled the production
of certain bacterial proteins (Horwitz, M.A., unpublished data). Colony type of
mutants had no bearing on intracellular multiplication or any other interaction
with monocytes studied.
Ultrastructurally, mutant L. pneumophila resembled wild-type L. pneumophila .
Like the wild-type, the mutants were bacillary in shape, had readily identifiable
cytoplasmic and outer membranes, frequently contained electron-lucent cyto-
plasmic vacuoles, and divided by a pinching nonseptate process.
Mutants Are Resistant to the Bactericidal Effects of Serum.
￿
Wild-type L. pneu-
mophila are resistant to the bactericidal effect of human serum in the presence
or absence of high-titer human anti-L. pneumophila antiserum (6). Mutant L.
pneumophila were examined for their sensitivity to complement. In the presence
or absence of anti-L. pneumophila antibody, CFU of Mutants 25 and 38 and of
wild-type L. pneumophila were not significantly reduced upon incubation for 1 h
0% serum; in contrast, CFU of a complement-sensitive strain of E. coli were
reduced by 2.5 logs in 10% serum and >6 logs in 50% serum (Table 1, Exp. A).
Both variants of Mutant 25, those forming colonies of compact morphology
(Mutant 25C) and those forming colonies of diffuse morphology (Mutant 25D),
were resistant to the bactericidal effects of serum in the presence or absence of
anti-L. pneumophila antibody (Table 1, Exp. B). These mutantswere also resistant
to the bactericidal effects of serum after 24 h of incubation (Table 1, Exp. C) .
Thus, like the wild-type, both Mutants 25 and 38 are resistant to complement
in the presence or absence of anti-L. pneumophila antibody. Therefore, theHORWITZ
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FIGURE 1 .
￿
Mutant L . pneumophila do not multiply in the
presence of monocytes . Wild-type L . pneumophila, Mutant
25C, or Mutant 25D were added to human monocytes in
monolayer culture, andthe cultures were incubated at 37°C
in 5% C02-95% air for 72 h. CFU/ml were determined
daily . Each data point represents the mean of triplicate
culture wells ± SE.
FIGURE 2 . Colony morphology of mutant L . pneumophila . Mutant L. pneumophila form
colonies of diffuse (left) and compact (right) type on CYE agar similar in morphology to those
formed by wild-type L . pneumophila . X 2 .
mutants, at least under tissue culture conditions, were not type I mutants as
defined above, i.e ., mutants unable to surviveextracellularly . This indicated that
the avirulent phenotype of the mutants reflected a defect in their capacity to
enter monocytes (type IIA), survive intracellularly in monocytes (type 1113), or
multiply intracellularly in monocytes (type IIC) . Subsequent experiments exam-
ined these possibilities .
Mutants Bind to Monocytes and Are Phagocytixed by Coiling Phagocytosis .
￿
The
capacity of mutant L . pneumophila to bind to monocytes was examined to
determine if avirulence for monocytes was a result of a failure of mutants to
enter monocytes and gain access to the intracellular milieu they require to
multiply under tissue culture conditions . All 44 mutant L . pneumophila clones
bound readily to monocytes . The percentage of monocytes that bound or
ingested mutant or wild-type L . pneumophila was comparable and independent
of colony morphology . The number of bacteria bound per monocyte differed
somewhat among the different bacteria tested (Table II) . More wild-type L .
pneumophila that form colonies typical in morphology to those ofL . pneumophila1316
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TABLE I
Viability ofMutant L. pneumophila in thePresence ofHuman Serum and Anti-
L. pneumophilaAntibody
Exp.
A
B
C
isolated from embryonated hens' eggs or guinea pigs (and thus referred to as
"standard" wild-type L. pneumophila) bound per monocyte than wild-type L.
pneumophila ofthe diffuse or compactcolony type. Comparable numbers ofwild-
type L. pneumophila of compact or diffuse colony type bound per monocyte;
Bacteria Initial CFU/ml
CFU/ml after I h incubation in 0, 10,
0% 10%
or 50% serum
50%
L. pneumophila, mutant 25 6.8 t 0.04 x 104 5.8 t 0.2 x 104 7.6 t0.2 x 104 7.0 t0.1 x 104
L. pneumophila, mutant 38 4.8 t0.01 x 104 4.3 t 0.01 x 104 5.3 t0.1 x 104 -
L. pneumophila, wild-type 6.4 t0.2 x 104 6.6 t 0.9 x 104 8.0 t0.3 x 104 5.2 ± 1 .0 x l0°
E.coli 2.8±0.1 x 107 8.0±0.3 x 10' 9.8±6.9 x 104 1 .5±1 .1 x l0,
CFU/ml after I h incubation with anti-L. pneumophila antibodyand
0, 10, or 50% serum
0% 10% 50%
L. pneumophila, mutant 25 6.8 t 0.04 x 104 7.6 t 0.1 x 104 6.9 t 0.1 x 104 6.8 ± 0.3 x 104
L. pneumophila, mutant 38 4.8 t 0.01 X 104 4.7 ± 0.02 x 104 3.3 t 0.03 x 104 2.0 t 0.07 x 104
L. pneumophila, wild-type 6.4 ± 0.2 X 104 7.4 ± 0.5 x 104 4.2 t0.04 x 104 2.2 t 0.5 X 104
E. coli 2.8 t 0.1 x 107 1 .2 ± 0.1 x 108 5.3 ± 3.6 x 104 7.8 t 1.6 x 100
CFU/ml after 1 h incubation in 0 or 25% serum
0% 25%
L. pneumophila, mutant 25C 1 .9 ± 0.02 x 104 2.0 ± 0.08 x 104 2.0 t 0.4 x 104
L. pneumophila, mutant 25D 8.0 ± 0.04 x 104 9.8 t 0.8 x 104 10.3 t 0.7 x 104
L. pneumophila, wild-type 3.4 ± 0.4 x 104 3.8 ± 0.4 x 1,)4 4.3 ± 0.8 x 104
E .coli 4.8±0.2 x 106 6.9±0.5 x 106 1.0±0.8 x 10'
CFU/ml after 1 h incubation with anti-L. pneumophila antibody and
0 or 25% serum
0% 25%
L. pneumophila, mutant 25C 1.9 ± 0.02 x 104 2.8 ± 0.05 x 104 2.0 ± 0.5 x 104
L. pneumophila, mutant25D 8.0 ± 0.04 x 104 8.9 ± 1 .3 x 104 6.3 ± 0.3 x 104
L. pneumophila, wild-type 3.4 t 0.4 X 104 5.8 ± 0.4 x 104 3.0 t 0.5 x 104
E .coh 4.8±0.2 x106 1.7±0.07x101 6.7t0.3 x106
CFU/ml after 1 h incubation with 0 or 25% serum
0% 25%
L. pneumophila, mutant 25C 2.1 ± 0.01 x 104 2.9 t 0.05 x 104 1.8±0.1 x 1o,
L. pneumophila, mutant 25D 3.8 t 0.4 x 104 1.8 t 0.2 x 104 3.3 t 0.07 x 104
L. pneumophila, wild-type 2.3 ± 0.06 x 10' 1.7 t 0.4 x 10' 1.9 t 0.8 x 10'
E . coli 5.6 ± 0.2 x 106 5.2 t 0.2 x 106 1.7 t 1 .1 x 102
CFU/ml after 24 h incubation with 0 or 25% serum
0% 25%
L. pneumophila, mutant 25C 2.1 ± 0.01 x 104 1.3 ± 0.06 x 104 1.5 t 0.1 x 104
L. pneumophila, mutant 25D 3.8 ± 0.4 x 104 1.7 t 0.1 x 104 4.9 t 0.01 x 10'
L. pneumophila, wild-type 2.3 t 0.06 x 10' 1.3 ± 0.3 x 102 5.0 ± 0.8 x 102
E .. coli 5.6 ± 0.2 x 106 4.4 t 0.2 x 106 2.8 t 2.3 x 102HORWITZ
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TABLE II
Capacity ofMonocytes to Bind or Ingest Mutant and Wild-
type L. pneumophila
Average
Wild-type or mutant L. pneumophila with the colonial morphology indicated
were incubated with monocytes as described in the text. The cells were fixed
and stained with fluorescein-conjugated anti-L. pneumophila antibody, exam-
ined by fluorescence microscopy, and 200 consecutive monocytes in each
preparation were examined forassociated bacteria.
* The index of monocyte-L. pneumophila association is the percentage of mon-
ocyteswith boundor ingestedL. pneumophila multiplied by theaveragenumber
of L. pneumophila per monocyte with >_ 1 associated bacteria.
however, fewer Mutant 25 L. pneumophila of diffuse colony type bound per
monocyte than Mutant 25 L. pneumophila of compact colony type in two inde-
pendent experiments.
Electron microscopy revealed that Mutants 25 and 38 of compact or diffuse
colony type,andwild-type L. pneumophila ofstandard, compact, ordiffuse colony
type were readily ingested by monocytes. All thesetypesofbacteria were ingested
by "coiling phagocytosis," as described previously for wild-type (standard) L.
pneumophila (8). In coiling phagocytosis, long monocyte pseudopods coil around
the bacteria as they are internalized.
Thus, the mutant L. pneumophila areall phagocytized efficiently by monocytes.
The mutants are not type IIA mutants, i.e., mutants avirulent because of an
inability to gain entry into monocytes.
Mutant L. pneumophila Survive Intracellularly in Monocytes but Do Not Repli-
cate. Mutants that gain entry into monocytes may be avirulent either because
of an inability to survive intracellularly or because of an inability to replicate.
The capacity of mutant L. pneumophila to survive intracellularly was examined
under two conditions: mutants were incubated with pelleted monocytes in the
cone of a centrifuge tube or mutants were incubated with monocytes in mono-
layer culture (Tables III and IV). Neither mutant nor wild-type bacteria were
killed by the monocytes under either ofthe two conditions ofincubation . During
the 2 h ofincubation in pelleted monocytes and during the first 4 h of incubation
in monocytes in monolayer culture, CFU of mutant and wild-type bacteria
changed relatively little and if anything slightly increased (Tables III and IV).
Between 4 and 24 h of incubation in monocytes in monolayer culture, CFU of
mutant L. pneumophila remained essentially unchanged, whereas CFU of wild-
type L. pneumophila increased 1 .8 log (Table IV), reflecting intracellular multi-
plication of wild-type L. pneumophila.
L. pneumophila
type
Percentage of
monocytes bind-
ingor ingesting
L. pneumophila
number of L.
pneumo-
phila/monocyte
with >_ 1 associ-
ated bacteria
Index ofmono-
hila association*
Wild-type, standard 75 5.0 375
Wild-type, compact 66 3.2 211
Wild-type, diffuse 74 3.4 252
Mutant 25, compact 70 3.4 238
Mutant 25, diffuse 60 2.4 1441318 CHARACTERIZATION OF MUTANT LEGIONELLA PNEUMOPHILA
TABLE III
Viability ofL. pneumophila Mutants Mixed andIncubated
with Pelleted Monocytes
Monocytes were incubatedwith wild-typeor mutant L. pneumophila in thecone
of a centrifuge tube for 0 or 2 h, lysed by sonication to release intracellular
bacteria, and CFU were determined. Data are the mean ± SE for duplicate
cultures.
* Alog CFU = (log CFU at endof incubation period, 2 h) - (log CFU at start of
incubation period, 0 h).
TABLE IV
Viability ofL. pneumophila MutantsBound to and Incubated with Adherent Monocytes
Monocytes in monolayerculture were infected with wild-type or mutant L. pneumophila, washed to
remove extracellular bacteria,incubatedfor 0, 4, or 24 h, lysed by sonication to release intracellular
bacteria, and CFU were determined. Data are mean ± SE fortriplicate cultures.
* Olog CFU =(log CFU at end of incubation period; 4 or 24 h, as indicated) - (log CFU at start of
incubation period; 0 or 4 h, as indicated).
Thus, mutant bacteria are not killed by monocytes and their avirulence results
from an inability to multiply intracellularly. The mutants are therefore type IIC
mutants as defined above.
Mutant L. pneumophila Do Not Form the Ribosome-lined Replicative Phagosome
Characteristic of Wild-type L. pneumophila. The defect in the capacity of mutant
L. pneumophila to multiply intracellularly was examined further by investigating
the capacity of the mutants to form the distinctive replicative phagosome char-
acteristic of wild-type L. pneumophila (9). After phagocytosis, wild-type L. pneu-
mophila form a ribosome-lined phagosome by a process that involves the sequen-
tial interaction of the phagosome with monocyte smooth vesicles, mitochondria,
and ribosomes and requires 4-8 h (9). The bacterium then multiplies within the
ribosome-lined vacuole.
Unlike phagosomes of wild-type L. pneumophila, phagosomes of mutant L.
pneumophila were not frequently surrounded by smooth vesicles and mitochon-
dria early (1 or 2 h) after ingestion or by ribosomes later after ingestion (Table
V; Fig. 3). At 1 or 2 h after ingestion, 85-96% of phagosomes of wild-type L.
pneumophila were surrounded by smooth vesicles, compared with 0-4% of
phagosomes of Mutants 25C, 25D, or 38C (Table V, Exps. A-C). Similarly, 40-
50% ofphagosomes of wild-type L. pneumophila were surrounded by mitochon-
dria, compared with 0-5% of phagosomes of the mutant L. pneumophila (Table
Mutant
CFU of L.
0h
pneumophila/ml
2h
Olog CFU
0-2 h*
Wild-type 3.8 ±0.1 x 102 6.8 ± 0.5 x 102 +0.25
Mutant 25 4.2 ± 0.6 x 102 7.3 ± 0.9 x 102 +0.25
Mutant 38 2.1 ± 0.1 x 10' 2.2 ± 0.1 x 10' +0.02
Mutant
CFU
0h
of L. pneumophila/ml
4h 24h 0-4 h
Alog CFU*
4-24 h 0-24 h
Wild-type 1.2±0.5x102 1.5±0.3x102 8.4±0.4x10' +0.1 +1.8 +1.9
Mutant 25C 4.5 ± 0.2 x 102 1.5 ± 0.2 x 10' 1.4 ± 0.1 x 10' +0.5 -0.03 +0.5
Mutant 25D 4.5±0.3x10' 1.1±0.1x10` 4.7±0.2x10' +0.4 -0.4 +0.02HORWITZ
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TABLE V
PhagosomeFormation by Mutant and Wild-type L. pneumophila
Monocyteswere infected with wild-typeor mutant L. pneumophila, washed to remove non-monocyte-
associated bacteria, incubatedfor 1, 2, 6, or 24 h, and fixed and processed for electron microscopy.
In each experiment, the percentage of 20 consecutive phagosomes surrounded by monocyte smooth
vesicles,mitochondria, or ribosomes was enumerated for each bacterium studied at each time point.
V, Exps. A-C). At 6 h after ingestion, 82-95% of phagosomes of wild-type L.
pneumophila were surrounded by ribosomes, compared with 0% ofphagosomes
of mutant L. pneumophila (Table V, Exps. B-D). At 24 h after ingestion,
phagosomes of Mutant 25C were still not surrounded by ribosomes (Table V,
Exps. C and D). Phagosomes of wild-type L. pneumophila could not be examined
at 24 h after ingestion because monocyte monolayers containing these bacteria
were destroyed by this time as a result of intracellular multiplication of these
bacteria.
Within 2 h of infection, phagosomes of mutant bacteria contained what
appeared to be lysosomal contents (Fig. 3,D-F), consistent with the finding that
these phagosomes fuse with lysosomes (see below). At 6 and 24 h after infection,
phagosomes of mutant bacteria frequently contained large amounts of membra-
nous material (Fig. 3, J-L).
There was no electron microscopic evidence of multiplication of mutant L.
pneumophila. At 24 h after ingestion, most phagosomes containedonly a single
bacterium (94% ofphagosomes examined in Exps. C and D).
Thus, in contrast to phagosomes of wild-type L. pneumophila, phagosomes of
mutant bacteria do not interact with monocyte smooth vesicles, mitochondria,
or ribosomes. In this respect, mutant bacteria resemble formalin-killed wild-type
Exp. L. pneumophila type Incubation
period
Phagosomes surrounded by:
Smooth vesi- Mitochon-
cles dria Ribosomes
h % % %
A Wild-type 1 90 50 0
Mutant-25D 1 0 3 0
Mutant 38C 1 0 5 0
B Wild-type 2 85 40 0
Mutant 25D 2 4 4 0
Mutant 38C 2 0 0 0
Wild-type. 6 15 0 82
Mutant 25D 6 4 4 0
Mutant 38C 6 0 0 0
C Wild-type 1 96 50 5
Mutant 25C 1 0 0 0
Mutant 25D 1 0 0 0
Wild-type 6 10 0 95
Mutant 25C 6 0 0 0
Mutant 25D 6 0 0 0
Mutant 25C 24 0 8 0
D Wild-type 6 13 13 94
Mutant 25 6 0 0 0
Mutant 25 24 0 0 01320
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bacteria . In contrast to formalin-killedL . pneumophila, which are rapidly digested
in monocytes so that by 4 h few bacteria remain intact, mutant L . pneumophila
are not digested in monocytes and appear fully intact at least up to 24 h after
ingestion (Fig . 3) .
Mutant L . pneumophila Do Not Inhibit Phagosome-Lysosome Fusion As Do Wild-
type L. pneumophila . Wild-type L . pneumophila inhibit fusion between the phag-
osome and monocyte lysosomes (10) . The capacity of mutant L . pneumophila to
do so was examined by preloading monocyte lysosomes with thorium dioxide,
an electron-opaque marker, infecting the monocytes with mutant or wild-typeL.HORWITZ
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pneumophila, and determining by electron microscopy whether phagosomes had
fused with lysosomes as evidenced by the presence of thorium dioxide within
them. Whereas only 9-10% of phagosomes containing live wild-type L. pneumo-
phila were fused at 1 h after ingestion, 57-95% of phagosomes containing
mutant L. pneumophila were fused (Table V1, Exps. A and B; Fig. 4,A, C, and
D) . Similarly, at 6 h after ingestion, no phagosomes containing live wild-type L.
pneumophila were fused, whereas 96% of phagosomes containing live Mutant 25
were fused (Table V1, Exp. C; Fig. 4,B, E, and F). At 24 h after ingestion, only
phagosomes containing mutant L. pneumophila could be examined because mon-
ocyte monolayers containing wild-type L. pneumophila were destroyed by this
time. The majority of phagosomes containing live Mutant 25 were fused at this
time as at earlier time points (Table V1, Exp. C; Fig. 4,G and H) . At all time
points, most phagosomes containing formalin-killed L. pneumophila, whether the
bacteria were wild-type or mutant, were fused (Table V1, Exps. A and C).
Thus, in parallel with their loss of capacity to form a distinctive ribosome-lined
phagosome, mutants have lost the capacity to inhibit phagosome-lysosome fusion.
The mutants remain intact and viable (as evidenced above by their capacity to
survive intracellularly) within a phagolysosome.
Biochemical Characterization ofMutants.
￿
Mutant L. pneumophila were partially
FIGURE 3.
￿
Morphology of phagosomes containing wild-type and mutant L. pneumophila.
Monocytes in monolayer culture were infected with wild-type L. pneumophila (A-C) or Mutant
25 (D-L), washed to remove non-monocyte-associated bacteria, incubated for 10 min to 24
h, andfixed forelectron microscopy. Studies conducted with Mutant 38 yielded similar results
to those conducted with Mutant 25.
(A-C) Phagosomes containing wild-type L. pneumophila interact sequentially with smooth
vesicles (A), mitochondria (B), and ribosomes(C), aprocess culminating in the formation ofa
ribosome-lined replicative vacuole (C). (A) Phagosome containing a wild-type bacterium at 1
h afterinfection. The phagosome is surrounded by smooth vesicles (arrows) that appear to be
fusing with and/or budding offfrom the phagosome membrane (X 26,000). (B) Phagosome
containing a wild-type bacterium i h afterinfection at later stage ofphagosome development.
Thephagosomeis surrounded by smooth vesicles andby six mitochondria (arrowheads) closely
apposed to the phagosomal membrane. As is frequently the case, the bacterium contains an
electron lucent fat vacuole (X 20,500). (C) Phagosome containing a wild-type bacterium at 6
h afterinfection. Thephagosome is surrounded by monocyte ribosomes (arrows) located at a
distance of ^-100 A from the phagosomal membrane. As is frequently the case at this point
after infection, the phagosomeis located in an invagination of themonocyte nuclear envelope
(x 28,500).
(D-L) Phagosomes containing mutant L. pneumophila do not interact with monocyte smooth
vesicles, mitochondria, or ribosomes. These phagosomes appear to fuse with lysosomes (see
Fig. 4), and at later stages of infection, they contain large amounts of membranous material.
The mutant bacteria remain intact, but do not replicate in the phagosome. (D) Phagosome
containing a mutant bacterium at 10 min afterinfection. The phagosomeappearsto be fusing
with a monocyte lysosome (arrow) (X 52,000). (E and F) Phagosomes containing mutant
bacteria at 2 h after infection. They typically contain what appears to be lysosomal contents
(arrowheads) sandwiched between the bacterium and inner phagosomal membrane. (E) X
39,500. (F) X 26,000. (G-K) Phagosomes containing mutant bacteria at 6 hafter infection. A
few phagosomes, as in G, appear devoid of nonbacterial contents, but most contain what
appear to be lysosomal contents (arrowheads) (H and I). Many phagosomes contain abundant
membranous material (arrows) by this point after infection (J and K). (G) X 52,000. (H) X
15,000. (1-K) X 26,000. (L) Phagosome containing mutant bacterium at 24 h after infection.
Phagosomes at this pointare typically largeandmany contain membranous andother material
(X 20,500).1322
￿
CHARACTERIZATION OF MUTANT LEGIONELLA PNEUMOPHILA
TABLE VI
Phagosome-Lysosome Fusion by Mutant and Wild-typeL. pneumophila
Monocytes containing lysosomes that had been prelabeled with thorium dioxide were infected with
live or formalin-killed, wild-type or mutant L. pneumophila, incubatedfor 1, 6, or 24 h, andprocessed
for electron microscopy. In each experiment, the percentage of >>_20 consecutive phagosomes that
were fused was determined for each bacterium studied at each time point.
characterized biochemically in an attempt to identify a specific molecular differ-
ence between mutant and wild-type L. pneumophila that might relate to the
difference in virulence between them. The total proteins, secretory proteins, and
LPS ofMutants 25 and 38 were compared with that ofwild-type L. pneumophila.
The total proteins were studied by SDS-PAGE ofwhole bacteria. The secretory
proteins were studied by radiolabeling the bacteria with [35S]cysteine during
broth culture, collecting and precipitating the supernatant proteins, and exam-
ining them autoradiographically. The LPSs were studied by isolating the mole-
cules, electrophoresing them, and silver staining the gels.
No consistent differences between wild-type and mutant L. pneumophila were
found in these studies (Figs. 5-7).
Discussion
This paper demonstrates that L. pneumophila, upon passage on suboptimal
medium, converts to a mutant form that is avirulent for human monocytes. The
basis for the avirulence is an inability to multiply intracellularly. In association
with this defect, the mutant has lost the the capacity to form the distinctive
ribosome-lined replicative phagosome characteristic ofwild-type L. pneumophila,
and it has lost the capacity to inhibit Phagosome-lysosome fusion. Earlier inter-
actions of mutant L. pneumophila with monocytes appear normal. The mutants
Exp. L. pneumophila type Incubation
period
h
Mean number
bacte-
riafPhagosome
Phagosomes
fused
%
Bacteria in
fusedphago-
somes
%
A Wild-type, live 1 1.05 10 14
Wild-type, dead 1 1.14 100 100
Mutant 251), live 1 1.32 90 93
Mutant 251), dead 1 1.44 100 100
Mutant 38C, live 1 1.25 95 96
Mutant 38C, dead 1 1.96 96 98
B Wild-type, live 1 1.18 9 8
Mutant 25C, live 1 1.12 71 63
Mutant 25D, live 1 1.05 57 59
C Wild-type, live 6 1.00 0 0
Mutant 25, live 6 1.14 96 96
Mutant 25, dead 6 1.22 100 100
Mutant 25, live 24 1.00 63 63
Mutant 25, dead 24 1.33 100 100HORWITZ
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bind to and are ingested by monocytes, and they enter monocytes by coiling
phagocytosis.
In all other respects examined, the mutant resembles the wild-type. The two
typesofbacteria have similarcolony morphology; both form compactand diffuse
colonies on CYE agar. The two types have similar ultrastructure; both are
typically appearing Gram-negative bacilli with a cytoplasmic and outer mem-
brane, both have electron-lucent fat vacuoles, and both divide by a pinching
nonseptate process. The two types are complement resistant in the presence or
absenceofspecific antibody. Biochemically, the twotypes ofbacteria have similar
structural and secretory protein profiles by SDS-PAGE, and similar LPS profiles.
Although mutant L. pneumophila do not multiply intracellularly, they are
capable of surviving within a phagolysosome in human monocytes. This typically
low pH intracellular compartment isrichin hydrolytic enzymes, and is sometimes
considered an inhospitable milieu for microorganisms. However, some intracel-
lular parasites are specially adapted for life in the phagolysosome. For example
Leishmania donovani carries out a variety ofphysiologic activities optimallyin the
low pH range (4.0-5.5) characteristic of the phagolysosome (19); this organism
is able to survive and multiply within the phagolysosome (20, 21). The ability of
mutant L. pneumophila to survive but not to multiply in the phagolysosome may
reflect suboptimal adaptation to intraphagolysosomal conditions. For example,
L. pneumophila multiplication in artificial media is dependent upon a relatively
high pH (optimally 6.9) (22), and in monocytes, wild-type L. pneumophila main-
tains a high pH in the distinctive phagosome in which it replicates (11). If the
pH ofthe phagolysosome in which mutant L. pneumophila reside is characteris-
tically low, mutant L. pneumophila would probably not be able to multiply within
it for this reason alone.
Previous studies (23, 24) have shown that avirulent L. pneumophila (Philadel-
phia 2 strain) obtained by passage of wild-type bacteria on suboptimal artificial
media convert back to virulence uponpassage through guinea pigs, embryonated
hens' eggs, or cultured human embryonic lung fibroblasts. In these studies, the
passaged bacteria were not reported as cloned from a single colony so it is not
known whether the conversion to virulence resulted from back mutation or the
selection ofresidual wild-type organisms in the passaged inocula.
Theavirulent mutant characterized in this paper has tremendous potential for
enhancing our understanding of the intracellular biology of L. pneumophila and
perhaps ofother intracellular parasites, such as Toxoplasma gondii and Chlamydia
psittaci, that follow similar pathways throughthe mononuclear phagocyte (9, 10).
Current studies are aimed at identifying the genetic defect in the avirulent
mutant, and subsequently theprecise molecular basis foravirulence. Such studies
may shed light on mechanisms underlying phagosome formation and inhibition
ofphagosome-lysosome fusion.
This mutant (type IIC), which survives but does not multiply intracellularly, is
one ofseveral avirulent phenotypes that might serve to enhance our understand-
ing of L. pneumophila-monocyte interaction. Mutants that are unable to enter
monocytes (type IIA), or mutants able to enter but not able to survive intracel-
lularly (type IIB), would also be extremely useful for this purpose. Future studies
will seek to obtain such mutants.1324
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FIGURE 5 .
￿
SDS-PAGE analysis of wild-type and mutant L . pneu-
mophila . Bacterial proteins were analyzed by SDS-PAGE (12.5%
acrylamide) and stained with Coomassie Blue . Molecular weight
standards were trypsin inhibitor (20,100), trypsinogen (24,000),
carbonic anhydrase (29,000), glyceraldehyde-3 phosphatedehydro-
genase (36,000), ovalbumin (45,000),andbovine albumin (66,000) .
Wild-type or mutant bacteria that form colonies of diffuse mor-
phologyhave less ofthe 28-kD major outermembrane proteinand
more ofa22-kD protein than bacteria that form colonies ofcompact
morphology . No consistent differences were found between wild-
type andmutant bacteria ofsimilar colony morphology. (A) Mutant
25, diffuse ; (B) Mutant 25, compact; (C) wild-type, diffuse; (D) wild-
type, compact ; (E) wild-type, standard .
Theavirulent mutant also hasgreat potential for enhancing ourunderstanding
of immunity to L . pneumophila . The mutant is nonlethal to guinea pigs, and
studies in this animal of its capacity to induce protective immunity after immu-
nization may provide new strategies for developing safe and effective vaccines
against L . pneumophila and other intracellular parasites .
Summary
Legionella pneumophila, the causativeagent of Legionnaires' disease, is a Gram-
negative bacterium and a facultative intracellular parasite that multiplies in
human monocytes and alveolar macrophages . In this paper, mutants of L.
pneumophila avirulent for human monocytes were obtained and extensively
characterized. The mutants were obtained by serial passage of wild-type L.
FIGURE 4 .
￿
Interaction of phagosomes containing wild-type and mutant L . pneumophila with
lysosomes . Monocytes in monolayer culture were preincubated with thorium dioxide, an
electron-opaque marker that is concentrated in monocyte lysosomes. The monocytes were
washed to remove uningested thorium dioxide, infected with wild-type (A and B) or Mutant
25 (C-H)L . pneumophila, incubated for 1, 6, or 24 h, and processed for electron microscopy
as described in the text . Studies conducted with Mutant 38 yielded results similar to those
conducted with Mutant 25 .
(A and B) Phagosomes containing wild-type L. pneumophila do not fuse with monocyte
lysosomes . (A) Phagosome (arrow) containing a wild-typeL. pneumophila at 1 h after infection .
The phagosome is surrounded by smooth vesicles and mitochondria as is typical at this point
after infection. The phagosome is in the vicinity of monocyte lysosomes (L), but it has not
fused with them as evidenced by the absence of electron-opaque material (thorium dioxide)
within it (x 30,000) . (B) Phagosome containing a wild-type bacterium at 6 h after infection .
The phagosome is lined by ribosomes (arrows), as is typical at this point after infection. The
phagosome has not fused with monocyte lysosomes (x 33,000) .
(C-H) Phagosomes containing mutant L. pneumophila fuse with monocyte lysosomes. (C and
D) Phagosomes containing mutant L . pneumophila at 1 h after infection . The phagosomes
contain thorium dioxide (arrows), indicating that they have fused with monocyte lysosomes.
(C and D) x 18,000. (E-H) Phagosomes containing mutant L. pneumophila at 6 h (E and F)
and 24 h (G and H) after infection . The phagosomes have fused with lysosomes and they
contain large amounts of thorium dioxide label . The bacteria remain intact within the
phagolysosome . (E andH) x 17,000 . (F and G) x 26,500 .1326
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FIGURE 6.
￿
Secretory proteins of wild-type and mutant
L . pneumophila. Secretory proteins were radiolabeled,
subjected to SDS-PAGE, and revealed autoradiogra~hi-
cally. Molecular weight standards were methylated 'C-
labeled bovine serum albumin (69,000 mol wt), ovalbu-
min (46,000), carbonic anhydrase (30,000), lactoglobulin
A (18,367), cytochrome c (12,300) . Both wild-type and
mutant bacteria released the 40-kD major secretory pro-
tein . (A and F) Mutant 25, diffuse; (B andG) Mutant 25,
compact ; (C) wild-type, standard ; (D) wild-type, compact ;
(E) wild-type, diffuse .
FIGURE 7.
￿
LPS of wild-type and mutant L . pneumophila . LPS was
isolated from wild-type and mutant L. pneumophila, and from E . coli
K12 (rough) andE. coli K- (smooth), subjected to SDS-PAGE, and the
gel stained with silver nitrate . 5 lug ofeach preparation were loaded on
the gel . The size distribution of LPS molecules of the three strains of
L . pneumophila was markedly different from that of LPS molecules
from the two strains ofE . coli . The average size ofLPS molecules of
L . pneumophila (B-D)wasgreaterthan that ofthe rough E . coli (A)but
less than that of smooth E . coli (E) . The size distribution andaverage
size ofLPS molecules from wild-type L. pneumophila (B) were similar
to thoseof LPS molecules of mutantL. pneumophila (C andD) . (A) E .
coli K12; (B) wild-type; (C) Mutant 25 ; (D) mutant 38 ; (E) E . coli K- .
pneumophila on suboptimal artificial medium . None of 44 such mutant clones
were capable of multiplying in monocytes or exerting a cytopathic effect on
monocyte monolayers . Under the same conditions, wild-type L . pneumophila
multiplied 2.5-4.5 logs, and destroyed the monocyte monolayers .
The basis for the avirulent phenotype was an inability of the mutants to
multiply intracellularly . Both mutant and wild-type bacteria bound to and were
ingested by monocytes, and both entered by coiling phagocytosis . Thereafter,
their intracellular destinies diverged . The wild-type formed a distinctive ribo-
some-lined replicative phagosome, inhibited phagosome-lysosome fusion, and
multiplied intracellularly . The mutant did not form the distinctive phagosome
nor inhibit phagosome-lysosome fusion . The mutant survived intracellularly but
did not replicate in the phagolysosome .
In all other respects studied, the mutant and wild-type bacteria were similar.
They had similar ultrastructure and colony morphology ; both formed colonies
of compact and diffuse type . They had similar structural and secretory protein
profiles and LPS profile by PAGE . Both the mutant and wild-type bacteria were
completely resistant to human complement in the presence or absence of high
titer anti-L . pneumophila antibody .
The mutant L. pneumophila have tremendous potential for enhancing our
understanding of the intracellular biology ofL . pneumophila and other parasitesHORWITZ
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that follow a similar pathway through the mononuclear phagocyte. Such mutants
also show promise for enhancing our understanding of immunity to L. pneumo-
phila, and they may serve as prototypes in the development of safe and effective
vaccines against intracellular pathogens.
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